Relative Energy Deficiency in Sports (REDs) in Swedish Athletes

NCT06371963 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2025-03-10

No results posted yet for this study

Summary

Background: Relative Energy Deficiency in Sport (REDs) describes impairment of health and performance due to problematic (long-term/severe) low energy availability (LEA), with or without eating disorders. LEA is frequently reported in sports with high training volumes, especially in leanness demanding sports, and 20% of female and 9% of male Norwegian national team athletes have been reported to have eating disorders. Potential trigger factors are e.g., dieting, injuries, coaching behavior, and subculture aspects e.g., focus on low body weight. The main questions that will be addressed are: 1. What is the prevalence of eating disorders and REDs among Swedish elite athletes and controls? 2. What is the impact of problematic LEA on health and performance aspects in both male and female athletes? Methods: National team athletes and gender and matched controls will be invited to an anonymous on-line survey. Elite athletes who agree to participate, will be invited to assessment of eating disorders, nutritional and physiological status (e.g., metabolic and endocrine markers, bone health, microbiota, dietary intake, energy availability, and performance).

Conditions

Sponsors & Collaborators

  • Swedish Olympic Committee

    collaborator UNKNOWN
  • Swedish Research Council for Sport Science

    collaborator OTHER
  • World Anti-Doping Agency

    collaborator OTHER
  • Linnaeus University

    lead OTHER

Principal Investigators

  • Anna Melin, PhD · Linnaeus University

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-10
Primary Completion
2024-05-30
Completion
2024-05-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06371963 on ClinicalTrials.gov